According to Markntel Advisors Report, Impotence Agents Market is expected to grow at a significant growth rate, and the analysis period is 2023-2028, considering the base year as 2022.Consistent monitoring and evaluating of market dynamics to stay informed and adapt your strategies accordingly. As a market research and consulting firm, we offer market research reports that focus on major parameters including Target Market Identification, Customer Needs and Preferences, Thorough Competitor Analysis, Market Size & Market Analysis, and other major factors. At the end, we do provide meaningful insights and actionable recommendations that inform decision-making and strategy development.
Impotence agents, also known as ED (Erectile Dysfunction) drugs or PDE-5 (phosphodiesterase type 5) inhibitors, are medications that help men achieve & maintain a penile erection sufficient for sexual activity. These agents work by blocking PDE5 and preventing the breakdown of cGMP (cyclic guanosine monophosphate), which relaxes smooth muscles in the penis’s arteries and allows a rush of blood to flow into the penis, thereby creating an erection firm enough for sexual intercourse. The most common impotence agents prescribed by healthcare professionals include Sildenafil (Viagra), Tadalafil (Cialis), Vardenafil (Levitra), & Avanafil (Stendra).
Global Impotence Agents Market Research Report & Summary:
The Global Impotence Agents Market is projected to grow at a CAGR of around 6.8% during the forecast period, i.e., 2023-28.
Time Period Captured in the Report:
- Historical Years: 2018-21
- Base Years: 2022
- Forecast Years: 2023-28
Who are the Key Players Operating in the Impotence Agents Market?
The top companies of the Impotence Agents Market ruling the industry are:
Pfizer Inc., Mylan N.V., Novartis AG, Hikma Pharmaceuticals Plc, Aurobindo Pharma, Abbvie Inc., Melinta Therapeutics, LLC, Bristol-Myers Squibb Company, GSK Plc, Bayer AG.
?In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report- https://www.marknteladvisors.com/query/request-sample/impotence-agents-market.html
(“Kindly use your official email ID for all correspondence to ensure seamless engagement and access to exclusive benefits, along with prioritized support from our sales team.”)
What is Included in Impotence Agents Market Segmentation?
The Impotence Agents Market explores the industry by emphasizing the growth parameters and categorizes including geographical segmentation, to offer a comprehensive understanding of the market dynamic. The further bifurcations are as follows:
- By Indication
- Erectile Dysfunction
- Others
- By Product
- Tablets
- Avanafil (Stendra)
- Sildenafil (Viagra)
- Tadalafil (Cialis)
- Vardenafil (Levitra)
- Injections
- Urethral Suppository
- Others
- Tablets
- By Distribution Channel
- Hospitals
- Pharmacies
- Online
- Retail
- By Company
- Revenue Shares
- Competition Characteristics
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
Explore the Complete Impotence Agents Market Analysis Report – https://www.marknteladvisors.com/research-library/impotence-agents-market.html
Global Impotence Agents Market Dynamics:
Globally Rising Prevalence of Erectile Dysfunction- Sedentary lifestyles with no physical activity and unhealthy dietary habits with increased consumption of alcohol, tobacco, fast food, etc., are leading to increasing cases of chronic disorders like diabetes, cardiovascular diseases, hormonal imbalances, obesity, & blood pressure, and, in turn, augmenting the prevalence of erectile dysfunction among men worldwide. In addition, the rising number of people with depression & emotional imbalance due to hectic work schedules are also leading to the growing burden of ED, thereby driving the Global Impotence Agents Market.
Global Impotence Agents Market Possible Restraint
Lack of Awareness among People Regarding ED- Men might feel embarrassed in seeking ED treatment owing to the stigma associated, which results in lower diagnosis rates. In addition, various side effects of using ED drugs, such as headache, nasal congestion, dizziness, & diarrhea, among others, discourage people from seeking treatment or stop them from taking medicines before the prescribed course is completed. Moreover, the increasing availability of fake or counterfeit products marketed at prices lower than patented ED medications also negatively impacts the demand for impotence agents. Hence, these aspects might hamper the growth of the Global Impotence Agents Market during 2023-28.
Need personalized insights? Click here to customize this report- https://www.marknteladvisors.com/query/request-customization/impotence-agents-market.html
Why Markntel Advisor Report?
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
For Further Queries:
Contact Us
MarkNtel Advisors
Email at –sales@marknteladvisors.com
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh – 201301, India
Related Reports:
